Tuberous sclerosis complex type 2 in a subgroup of 7 pediatric patients
DOI:
https://doi.org/10.18203/2320-6012.ijrms20230184Keywords:
Tuberous sclerosis complex, Tuberous sclerosis, TSC2, PediatricsAbstract
Tuberous sclerosis complex (TSC) is a multisystemic genetic disorder with autosomal dominant inheritance, characterized by hamartomas that affect multiple organs, including the central nervous system, skin, heart, kidneys, and lungs. It occurs due to variants in the tumor suppressor genes TSC1 or TSC2. In this case series, we present a subgroup of 7 pediatric patients with variants in the TSC2 gene and discuss their genotypes, phenotypes as well as genotype-phenotype correlation.
Metrics
References
Northrup H, Krueger DA, Roberds S, Smith K, Sampson J, Korf B et al. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr neurol. 2013;49(4):243-54.
Sadowski K, Kotulska K, Schwartz RA, Jóźwiak S. Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review. J Eur Acad Dermatol Venereol. 2016;30(5):86-94.
Jacks SK, Witman PM. Tuberous Sclerosis Complex: An Update for Dermatologists. Pediatr Dermatol. 2015;32(5):63-70.
MacKeigan JP, Krueger DA. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex. Neuro Oncol. 2015;17:1550-9.
Islam MP, Roach ES. Tuberous sclerosis complex. Handb clin neurol. 2015;13(2):97-109.
Au KS, Rodriguez JA, Finch JL, Volcik KA, Roach ES, Delgado MR et al. Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Am J Hum Genetics. 1998;62(2):286-94.
Nellist M, Verhaaf B, Goedbloed MA, Reuser AJ, van den Ouweland AM, Halley DJ. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin–hamartin complex. Hum Mol Genet. 2001;10(25):2889-98.
Milunsky A, Shim SH, Ito M, Jaekle RK, Bassett LL, Brumund MR, Milunsky JM. Precise prenatal diagnosis of tuberous sclerosis by sequencing the TSC2 gene. Prenatal Diagnosis. Int Society Prenatal Diagnosis. 2005;25(7):582-5.
Niida Y, Lawrence‐Smith N, Banwell A, Hammer E, Lewis J, Beauchamp RL, Sims K, Ramesh V, Ozelius L. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Hum mutant. 1999;14(5):412-22.
Le Caignec C, Kwiatkowski DJ, Küry S, Hardouin JB, Melki J, David A. Three independent mutations in the TSC2 gene in a family with tuberous sclerosis. Eur J Hum Genet. 2009;17(9):1165-70.
Rosset C, Vairo F, Bandeira IC, Correia RL, De Goes FV, Da Silva RT et al. Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis. PLoS One. 2017;12(10):e0185713.
Curatolo P, Moavero R, Roberto D, Graziola F. Genotype/phenotype correlations in tuberous sclerosis complex. Semin pediatr neurol. 2015;22(4):259-73.
Au KS, Williams AT, Roach ES, Batchelor L, Sparagana SP, Delgado MR et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 2007;9(2):88-100.
Downloads
Published
How to Cite
Issue
Section
